Sacituzumab tirumotecan versus chemotherapy in previously treated locally recurrent or metastatic triple-negative breast cancer: final overall survival analysis of the Phase III OptiTROP-Breast01

Annals of Oncology · Elsevier

Аннотация

Publication date: Available online 26 October 2026 Source: Annals of Oncology Author(s): B. Xu, Y. Yin, Y. Fan, Q. Ouyang, L. Song, X. Wang, W. Li, M. Li, X. Yan, S. Wang, T. Sun, Y. Teng, X. Tang, Z. Tong, Z. Sun, G. Liu, Y. Diao, X. Jin, J. Ge

Читать у издателя →

Похожие статьи